{"id":"W2064843404","doi":"10.1016/j.gtc.2014.05.013","title":"Update on Ustekinumab for the Treatment of Crohn's Disease","year":2014,"lang":"en","type":"review","venue":"Gastroenterology Clinics of North America","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Disease; Monoclonal antibody; Interleukin 23; Clinical trial; Immunology; Natalizumab; Immune system; Internal medicine; Antibody; Adalimumab; Interleukin 17","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008565064,0.0008037745,0.001758468,0.002216629,0.0002606323,0.001199656,0.0009660854,0.001434608,0.005662834],"category_scores_gemma":[0.001625202,0.0003090326,0.0007835187,0.001765052,0.0003791689,0.00137511,0.0007151149,0.002488895,0.002242903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006788054,"about_ca_system_score_gemma":0.001337154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001443609,"about_ca_topic_score_gemma":0.004402014,"domain_scores_codex":[0.9996966,0.00006516909,0.00005344431,0.0000319097,0.0001235702,0.00002936961],"domain_scores_gemma":[0.9992827,0.0003311364,0.0001056394,0.00001326591,0.0001947492,0.00007256352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001597243,0.00007038524,0.000157468,0.01272067,0.0001315656,0.0002912028,0.0000376689,0.0002472776,0.0008640122,0.001507954,0.1364426,0.8473694],"study_design_scores_gemma":[0.00007585526,0.000100492,0.0005747715,0.004058484,0.0002780424,0.0009480141,0.00002774907,0.00008740251,0.0001592687,0.0006448159,0.9930297,0.00001549529],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000821194,0.9971499,0.00009228197,0.0007462525,0.0008867827,0.000005617299,0.00003976841,0.000009897649,0.0009874819],"genre_scores_gemma":[0.0005140994,0.9962366,0.0002570782,0.001122927,0.0009397,0.000007160005,0.00007020652,0.000002347813,0.0008499207],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005662834,"threshold_uncertainty_score":0.01894403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0199803389925453,"score_gpt":0.314748752772569,"score_spread":0.2947684137800237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}